 |  The biotech industry dreams of automating millions of biological experiments on mass- produced chips. Colleagues say Steve Quake has the creativity, intellect and ambition to make it happen. When Quake was a Stanford University postdoc, he investigated the behav- ior of biological polymers. After becoming a Caltech professor he developed his first micro- fabricated tools, which use electric fields to sort cells and manipulate DNA molecules. Soon thereafter, Quake used soft lithography to build the first set of microvalves and pumps practical enough to be mass-produced, a key step toward developing the hotly anticipated chips. In 1999, Quake and some former college buddies founded San Francisco-based Fluidigm to supply his patented equipment and intellectual property to life science and pharmaceutical companies. Fluidigm has received $50 million in capital and recently signed a deal to supply Glaxo Smith Kiine. Now a tenured professor. Quake divides his time between researching the structure and function of proteins and devising more-sophisticated micro fluidic tools.
| | QUAKE | | STEPHEN | | AGE 32 | | MATERIALS | | CALTECH |
|
|
產業智庫 
|